YOOM YOOMA WELLNESS INC

YOOMA WELLNESS INC. ANNOUNCES ANTICIPATED DELAY IN ANNUAL FILINGS AND CEASE TRADE ORDER

YOOMA WELLNESS INC. ANNOUNCES ANTICIPATED DELAY IN ANNUAL FILINGS AND CEASE TRADE ORDER

Toronto, Ontario, April 21, 2023 (GLOBE NEWSWIRE) -- Yooma Wellness Inc. (CSE: YOOM, AQSE: YOOM) ("Yooma" or the "Company") today announced that it anticipates it will be unable to file the following periodic disclosure documents (the “Annual Filings”) by the filing deadline of May 1, 2023:

  • Annual audited financial statements for the year ended December 31, 2022;
  • Management’s discussion and analysis for the year ended December 31, 2022; and
  • CEO and CFO certifications of the annual filings for the year ended December 31, 2022.



By virtue of being unable to file the Annual Filings by the filing deadline, the Company anticipates that it will be issued a failure-to-file cease trade order (“CTO”) by the Ontario Securities Commission.

The financial and operational challenges faced by the Company over the past several months have consumed significant financial and management resources, resulting in inevitable delays which have impacted on the ability of the Company's external auditor to commence and conduct its audit procedures. The Company has now resolved these issues to the extent required to allow the audit to proceed and is working diligently and expeditiously with its auditors to complete the Annual Filings as soon as possible. The Company anticipates that it will complete the Annual Filings on or before May 31, 2023, and revocation of the CTO is expected to occur within a few days after the Annual Filings are made.

A copy of the CTO will be posted on the Ontario Securities Commission website once issued. The Company expects that the CTO will provide that a beneficial security holder of the Company who is not, and was not at the date of the CTO, an insider or control person of the Company, may sell securities of the Company acquired before the date of the CTO if: (a) the sale is made through a “foreign organized regulated market”, as defined in section 1.1 of the Universal Market Integrity Rules of the Investment Industry Regulatory Organization of Canada; and (b) the sale is made through an investment dealer registered in a jurisdiction of Canada in accordance with applicable securities legislation. Holders of the Company’s securities are urged to consult with their own investment advisors or legal counsel about the implications of the CTO.

There can be no assurance that the Company will be able to remedy its filing default and have the CTO lifted in a timely manner or at all.

The Company confirms that there are no insolvency proceedings against it as of the date of this press release. The Company also confirms that there is no other material information concerning the affairs of the Company that has not been generally disclosed as of the date of this press release.

About Yooma

Yooma's mission is to build a global leader in the marketing, distribution, and sale of wellness products including hemp seed oil and hemp-derived and cannabinoid (CBD) ingredients. The company leverages strategically curated sales channels and ecommerce networks to deliver a diverse mix of wellness products through operating subsidiaries in the United Kingdom, France and Japan. Learn more at .

Issuer Contact:

Jordan Greenberg, CEO

Email:

Phone: 1-512-823-1678

Notice regarding Forward-Looking Statements

All information included in this press release, including any information as to future financial or operating performance and other statements of Yooma that express management’s expectations or estimates of future performance or activities, other than statements of historical fact, constitute forward-looking information or forward-looking statements (collectively, “forward-looking statements”) within the meaning of applicable securities laws and are based on expectations, estimates and projections as of the date hereof. Forward-looking statements are included for the purpose of providing information about management’s current expectations and plans relating to the future. Wherever possible, words such as “will”, “anticipates”, “expected”, “intendsor the negative of these words or other variations thereof, have been used to identify such forward-looking information. Specific forward-looking statements include, without limitation, all disclosure regarding future results of operations, economic conditions and anticipated courses of action, including statements about the issuance of any cease trade orders and the contents of these orders, the Company’s ability to file its Annual Filings on the timeliness described above, and the subsequent revocation of any cease trade orders.

There are many risks and uncertainties that may affect forward-looking statements including, among others, regulatory risk in each jurisdiction in which Yooma does or intends to operate; the uncertainties, effects of and responses to the COVID-19 pandemic; reliance on licenses; competition; dependence on senior management and key personnel; general business risk and liability; regulation of the CBD industry; changes in laws, regulations and guidelines; compliance with laws; limited operating history; unfavourable publicity or consumer perception; product liability, risks related to intellectual property; product recalls; difficulties with forecasts; management of growth; litigation; Yooma’s ability to effectively integrate existing and future acquisition targets into its platform; the effects of competition in the industry; the requirement for increasingly innovative product solutions and service offerings; trends in customer growth; the availability of financing to support future growth and working capital requirements, transactional activity and operations; sufficiency of current working capital to support future operating and working capital requirements; Yooma’s ability to prepare and file its Annual Filings before the date specified herein; and other matters which are beyond the control of Yooma. Although the forward-looking statements contained herein reflect management's current beliefs and reasonable assumptions based upon information available to management as of the date hereof, Yooma cannot be certain that actual results will be consistent with such forward-looking information. Yooma cautions you not to place undue reliance upon any such forward-looking statements. Yooma disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by applicable law. Nothing herein should be construed as either an offer to sell or a solicitation to buy or sell securities of Yooma.



EN
21/04/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on YOOMA WELLNESS INC

 PRESS RELEASE

YOOMA WELLNESS ANNOUNCES BANKRUPTCY FILING

YOOMA WELLNESS ANNOUNCES BANKRUPTCY FILING Toronto, Ontario, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Yooma Wellness Inc. (“Yooma” or the "Company") (CSE: YOOM) (AQSE: YOOM), a global multi-branded wellness platform, including CBD products and other wellness brands, today announces that it has filed an assignment in bankruptcy pursuant to the Bankruptcy and Insolvency Act (Canada). Richter Inc. was appointed as Trustee of the estate.  Issuer Contact:Jordan Greenberg, CEOEmail: Phone: 1-512-823-1678

 PRESS RELEASE

YOOMA WELLNESS INC. ANNOUNCES SALE OF VITALITY CBD

YOOMA WELLNESS INC. ANNOUNCES SALE OF VITALITY CBD Toronto, Ontario, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Yooma Wellness Inc. (CSE: YOOM, AQSE: YOOM) ("Yooma" or the "Company") today announced that its wholly-owned subsidiary Yooma Europe Limited (“Yooma Europe”) has completed the sale of Birmingham-based Vitality CBD Limited (“Vitality”), a UK-focused CBD company, for a total consideration of US$2.0 million (the “Disposal”) to Psilobrain Therapeutics Inc. (“Psilobrain”). Psilobrain is a private Canadian biotech company that uses the latest in psychedelic medicine to design products that fa...

 PRESS RELEASE

YOOMA WELLNESS INC. ISSUED CEASE TRADE ORDER FOR DELAY IN ANNUAL FILIN...

YOOMA WELLNESS INC. ISSUED CEASE TRADE ORDER FOR DELAY IN ANNUAL FILINGS Toronto, Ontario, May 08, 2023 (GLOBE NEWSWIRE) -- Yooma Wellness Inc. (CSE: YOOM, AQSE: YOOM) ("Yooma" or the "Company") today announced that it has been issued a cease trade order (“CTO”) by the Ontario Securities Commission (“OSC”) in connection with its failure to file its audited annual financial statements for the financial year ended December 31, 2022, together with the corresponding management discussion and analysis and CEO/CFO certifications, (collectively, the “Annual Filings”) by the deadline of May 1, 20...

 PRESS RELEASE

YOOMA WELLNESS INC. ANNOUNCES ANTICIPATED DELAY IN ANNUAL FILINGS AND ...

YOOMA WELLNESS INC. ANNOUNCES ANTICIPATED DELAY IN ANNUAL FILINGS AND CEASE TRADE ORDER Toronto, Ontario, April 21, 2023 (GLOBE NEWSWIRE) -- Yooma Wellness Inc. (CSE: YOOM, AQSE: YOOM) ("Yooma" or the "Company") today announced that it anticipates it will be unable to file the following periodic disclosure documents (the “Annual Filings”) by the filing deadline of May 1, 2023: Annual audited financial statements for the year ended December 31, 2022;Management’s discussion and analysis for the year ended December 31, 2022; andCEO and CFO certifications of the annual filings for the year e...

 PRESS RELEASE

YOOMA ANNOUNCES OPERATIONAL UPDATES

YOOMA ANNOUNCES OPERATIONAL UPDATES Yooma Announces an Exit from Japan and Potential Sale of Assets and Wind-Down of Operations Toronto, Ontario, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Yooma Wellness Inc. (“Yooma” or the "Company") (CSE: YOOM) (AQSE: YOOM), a wellness platform that and markets a portfolio of CBD and wellness brands, today provides a corporate update. The Company is engaged in an ongoing operational restructuring aimed at addressing depressed market conditions in the CBD wellness industry, the Company’s increasing liquidity constraints and lack of working capital. The initia...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch